Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

News in brief

MSD has selected Catalent to manufacture two recently approved sublingual pollen extract drugs using its Zydis formulation platform.

Opko Health has agreed to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. 

Novartis has agreed to acquire GlaxoSmithKline’s oncology pipeline for $16bn, while GSK will acquire Novartis’ vaccine business, excluding the flu vaccines, for $7bn.

The British Generic Manufacturers Association (BGMA) and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) will launch a forum for the generics industry to discuss manufacturing and quality issues.

Global Industry News

People on the Move

Outsourcing: who's going places? from Outsourcing-Pharma.com

Our round-up of who to watch this week in contract pharma starts with executive changes at PPD.

BREAKING NEWS

Biogen Idec selects Quintiles in 5-year strategic partnership from Outsourcing-Pharma.com

Biogen Idec’s five-year deal is the latest example of biopharma embracing the strategic partnership model, but the choice of Quintiles is somewhat of a surprise, according to ISI analyst Ross Muken.

EC-pharma research collaboration could provide opportunities for CROs from Outsourcing-Pharma.com

CROs could benefit from a €3bn ($4.1bn) research programme run jointly by the European Commission and the pharmaceutical industry, according to ACRO.

SAS platform used to share big pharma cancer trial data from Outsourcing-Pharma.com

SAS, a provider of tools for data and health analysis, will supply the platform for a project sharing oncology data from studies by AstraZeneca, Janssen R&D, Pfizer and Sanofi.

Generation of biobetters could push out biosimilar development, says expert from BioPharma-Reporter.com

The latest generation of “biobetters” which are engineered to be more effective than branded biologics are hitting the market before biosimilars and could make development of the latter pointless, an expert has said.

Quality of Life shown in robust Q1 for Thermo Fisher from BioPharma-Reporter.com

Q1 revenues for Thermo Fisher’s Life Sciences Solutions business shot up 384% year-over-year in a quarter that saw the integration of Life Technologies.

Epirus hopes to bring its infliximab biosimilar to EU in merger with Zalicus from BioPharma-Reporter.com

Epirus and Zalicus have agreed to merge in order to focus on the development and manufacture of biosimilars.

Spotlight

EMA to rejig variations procedures and industry contact staff in April

EMA to rejig variations procedures and industry contact staff in April

Pharmaceutical firms working in Europe may need to update their address books next month after more reorganisation...

Janssen Button? Will GSK's F1 team up prompt other collaborations?

Janssen Button? Will GSK's F1 team up prompt other collaborations?

GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow...

Indian API maker slammed with US FDA Warning over data issues

Indian API maker slammed with US FDA Warning over data issues

Failure in maintaining test and production data has landed an Indian API maker with a Warning Letter...

US FDA issues new bioavailability guidelines

US FDA issues new bioavailability guidelines

The US FDA has published guidance of how sponsors should best document the bioavailability of products for...

Bioavailability breakthrough key to new cancer drug OKed in Japan

Bioavailability breakthrough key to new cancer drug OKed in Japan

Japan has become the first country to approve a new cancer pill that treats disease by interfering...

Key Industry Events

 

Access all events listing

Our events, Events from partners...